Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -3.94% | 74.67 | 1.0% | $1808.50m | |
| AMGN | Amgen, Inc. | -1.32% | 208.78 | 1.3% | $898.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.55% | 501.51 | 2.6% | $832.58m | |
| BIIB | Biogen, Inc. | -3.27% | 301.21 | 1.5% | $768.55m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.99% | 247.67 | 1.9% | $644.24m | |
| MRNA | Moderna, Inc. | -7.56% | 32.02 | 0.0% | $518.77m | |
| ILMN | Illumina, Inc. | 0.95% | 280.64 | 3.5% | $494.32m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.24% | 94.72 | 2.0% | $299.75m | |
| A | Agilent Technologies, Inc. | -0.46% | 74.02 | 1.6% | $226.92m | |
| INCY | Incyte Corp. | 1.82% | 86.66 | 2.5% | $218.22m | |
| EXAS | EXACT Sciences Corp. | 0.53% | 62.60 | 21.0% | $178.66m | |
| SGEN | Seattle Genetics, Inc. | -2.09% | 121.87 | 6.1% | $164.60m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -3.55% | 79.83 | 4.3% | $153.92m | |
| IMMU | Immunomedics, Inc. | 0.69% | 18.91 | 11.9% | $120.80m | |
| NVAX | Novavax, Inc. | -7.45% | 14.90 | 114.7% | $113.95m |
Company Profile
Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD.